Company news
Resonance Health Ltd news in 2016
Resonance Health Ltd's news releases, calls and decks from 2016, newest first.
Results Recommending Use of FerriScan in Sickle Cell Disease
November 10, 2016
Resonance Health commences involvement in diabetes study
October 13, 2016
Bone Marrow Iron - Regulatory Submission
September 23, 2016
Expansion of Involvement in Pharmaceutical Clinical Trial
September 7, 2016
HepaFat-Scan International Scientific Journal
August 10, 2016
Operational Update
June 14, 2016
New UK Standards recommend FerriScan
May 30, 2016
Appendix 4C Quarterly Cashflow Report
April 29, 2016
Placement and entitlements offer to raise $5.1million
March 30, 2016
Half Year Accounts
February 25, 2016
New Clinical Trial
February 11, 2016
CSIRO Collaboration
February 10, 2016
Decks in 2016
- Shareholder Meeting (November 2016)
Shareholder meeting · 15 slides · Nov 24, 2016
- Investor Presentation (March 2016)
Investor deck · 19 slides · March 2016